| 12172986 |
Splicing modulator antibody-drug conjugates and methods of use |
Ermira Pazolli, Silvia Buonamici, Thiwanka Samarakoon, Sudeep Prajapati, Nathan Elliott Fishkin +13 more |
2024-12-24 |
| 11945807 |
Splicing modulator antibody-drug conjugates and methods of use |
Ermira Pazolli, Silvia Buonamici, Thiwanka Samarakoon, Sudeep Prajapati, Nathan Elliott Fishkin +13 more |
2024-04-02 |
| 11833119 |
Combination therapies for the treatment of hepatocellular carcinoma |
Anand Selvaraj |
2023-12-05 |
| 11761045 |
Splice variants associated with neomorphic SF3B1 mutants |
Lihua Yu, Kian Huat Lim, Jacob D. Feala, Silvia Buonamici, Yoshiharu Mizui +4 more |
2023-09-19 |
| 11524009 |
Combination comprising at least one spliceosome modulator and at least one inhibitor chosen from BCL2 inhibitors, BCL2/BCLxL inhibitors, and BCLxL inhibitors and methods of use |
Daniel Aird, Laura Corson, Ping Zhu, Markus Warmuth, Silvia Buonamici +1 more |
2022-12-13 |
| 11357769 |
Drug combinations for reducing cell viability and/or cell proliferation |
Anand Selvaraj |
2022-06-14 |
| 11352348 |
Splicing modulator antibody-drug conjugates and methods of use |
Ermira Pazolli, Silvia Buonamici, Thiwanka Samarakoon, Sudeep Prajapati, Nathan Elliott Fishkin +13 more |
2022-06-07 |
| 11083722 |
Combination therapies for the treatment of breast cancer |
Craig D. Karr, Manav Korpal, Nathalie Rioux |
2021-08-10 |
| 10953013 |
Biomarkers of response to NAE inhibitors |
Cyril Benes, Stephen J. Blakemore, Jonathan L. Blank, Eric S. Lightcap, George J. Mulligan +2 more |
2021-03-23 |
| 10889866 |
Splice variants associated with neomorphic SF3B1 mutants |
Lihua Yu, Kian Huat Lim, Jacob D. Feala, Silvia Buonamici, Yoshiharu Mizui +4 more |
2021-01-12 |
| 10851065 |
Tetrasubstituted alkene compounds and their use |
Mark G. Bock, Ming-Hong Hao, Manav Korpal, Vijay Kumar Nyavanandi, Xiaoling Puyang +4 more |
2020-12-01 |
| 10745387 |
Crystalline form of (2S,3S,6S,7R,10R,E)-7,10-dihydroxy-3,7-dimethyl-12-oxo-2-((R,2E,4E)-6-(piridin-2-yl)hepta-2,4-dien-2-yl)oxacyclododec-4-en-6-yl-4-methylpiperazine-1-carboxylate and methods of use thereof |
Gregg F. Keaney, John Wang, Baudouin Gérard, Kenzo Arai, Xiang LIU +19 more |
2020-08-18 |
| 9827246 |
Biomarkers of response to NAE inhibitors |
Stephen J. Blakemore, Bin Li, George J. Mulligan, Matthew C. Schu |
2017-11-28 |
| 9796683 |
Tetrasubstituted alkene compounds and their use |
Mark G. Bock, Ming-Hong Hao, Manav Korpal, Vijay Kumar Nyavanandi, Xiaoling Puyang +4 more |
2017-10-24 |
| 9481669 |
Pladienolide pyridine compounds and methods of use |
Gregg F. Keaney, John Wang, Baudouin Gérard, Kenzo Arai, Xiang LIU +17 more |
2016-11-01 |
| 8980850 |
Administration of a NEDD8-activating enzyme inhibitor and hypomethylating agent |
— |
2015-03-17 |
